Background Late-stage breast cancer contributes to a growing number of deaths in sub-Saharan Africa (SSA) but few studies ...
The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...
Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. When Michael J. Fox and Stephen Hawking publicly shared their personal ...
California urgent care staff fired after posting ‘dehumanizing’ TikTok mocking patients in exam room
A group of brazen California health care workers were fired for posting a “dehumanizing” TikTok video that mocked their patients in urgent-care exam rooms. The since-deleted video shows several former ...
Objectives This study aimed to investigate the knowledge, attitude and practice (KAP) of primary care ophthalmologists regarding fundus examination during the perioperative period of cataract surgery ...
I’m a Doctor. I Never in a Million Years Thought I’d Do What I’m Doing Now to Connect With Patients.
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. I am a proud late adopter of new ...
Objective Patients with non-ST segment elevation acute coronary syndrome (NSTEACS) admitted into emergency department are usually combined with a high number of comorbidities. Charlson Comorbidity ...
A new method is helping some deal with chronic pain after an amputation. Kevin McNerney had been dealing with chronic foot pain and neuropathy for years when doctors at UVA Health suggested amputation ...
Federal immigration authorities detained a woman seeking medical care at the National Institutes of Health’s flagship research hospital, according to an internal document and an NIH official briefed ...
PONTE VEDRA, Fla.--(BUSINESS WIRE)--Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company focused on developing transformative therapeutics that specifically address limitations of ...
Allogene Therapeutics, Inc. (NASDAQ:ALLO) on Friday said it has selected standard fludarabine and cyclophosphamide (FC) as the lymphodepletion regimen to be used in its ALPHA3 study evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback